GGHC
AGN

Gilder Gagnon Howe & Co’s Allergan plc AGN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,439
Closed -$295K – 313
2017
Q3 		$295K Sell
1,439
-227
-14% -$52.8K ﹤0.01% 239
2017
Q2 		$405K Buy
1,666
+9
+0.5% +$2.12K 0.01% 226
2017
Q1 		$396K Sell
1,657
-1
-0.1% -$233 0.01% 218
2016
Q4 		$348K Sell
1,658
-22,146
-93% -$4.59M 0.01% 203
2016
Q3 		$5.48M Sell
23,804
-780
-3% -$191K 0.09% 122
2016
Q2 		$5.68M Buy
24,584
+23,869
+3,338% +$5.5M 0.11% 107
2016
Q1 		$192K Buy
715
+152
+27% +$43.5K ﹤0.01% 198
2015
Q4 		$176K Buy
+563
New +$168K ﹤0.01% 212

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Gilder Gagnon Howe & Co's AGN Position: Q4 2017 in Review

Gilder Gagnon Howe & Co sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,439 shares — an estimated $295K sold.

Gilder Gagnon Howe & Co first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $5.68M in Q2 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Gilder Gagnon Howe & Co reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 1,439 Allergan plc shares in Q4 2017, an estimated $295K.
  • Gilder Gagnon Howe & Co first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Gilder Gagnon Howe & Co's Allergan plc position peaked at $5.68M in Q2 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2017, filed 31 Jan 2018.